Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150, Vienna, Austria.
J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18.
Extrapyramidal movement disorders include hypokinetic rigid and hyperkinetic or mixed forms, most of them originating from dysfunction of the basal ganglia (BG) and their information circuits. The functional anatomy of the BG, the cortico-BG-thalamocortical, and BG-cerebellar circuit connections are briefly reviewed. Pathophysiologic classification of extrapyramidal movement disorder mechanisms distinguish (1) parkinsonian syndromes, (2) chorea and related syndromes, (3) dystonias, (4) myoclonic syndromes, (5) ballism, (6) tics, and (7) tremor syndromes. Recent genetic and molecular-biologic classifications distinguish (1) synucleinopathies (Parkinson's disease, dementia with Lewy bodies, Parkinson's disease-dementia, and multiple system atrophy); (2) tauopathies (progressive supranuclear palsy, corticobasal degeneration, FTLD-17; Guamian Parkinson-dementia; Pick's disease, and others); (3) polyglutamine disorders (Huntington's disease and related disorders); (4) pantothenate kinase-associated neurodegeneration; (5) Wilson's disease; and (6) other hereditary neurodegenerations without hitherto detected genetic or specific markers. The diversity of phenotypes is related to the deposition of pathologic proteins in distinct cell populations, causing neurodegeneration due to genetic and environmental factors, but there is frequent overlap between various disorders. Their etiopathogenesis is still poorly understood, but is suggested to result from an interaction between genetic and environmental factors. Multiple etiologies and noxious factors (protein mishandling, mitochondrial dysfunction, oxidative stress, excitotoxicity, energy failure, and chronic neuroinflammation) are more likely than a single factor. Current clinical consensus criteria have increased the diagnostic accuracy of most neurodegenerative movement disorders, but for their definite diagnosis, histopathological confirmation is required. We present a timely overview of the neuropathology and pathogenesis of the major extrapyramidal movement disorders in two parts, the first one dedicated to hypokinetic-rigid forms and the second to hyperkinetic disorders.
锥体外系运动障碍包括运动减少性僵硬和运动过多或混合性形式,大多数源自基底节(BG)及其信息回路的功能障碍。简要回顾了 BG 的功能解剖、皮质-BG-丘脑皮质和 BG-小脑回路连接。锥体外系运动障碍机制的病理生理分类区分了(1)帕金森综合征,(2)舞蹈症和相关综合征,(3)肌张力障碍,(4)肌阵挛综合征,(5)投掷症,(6)抽动症和(7)震颤综合征。最近的遗传和分子生物学分类区分了(1)突触核蛋白病(帕金森病、路易体痴呆、帕金森病痴呆和多系统萎缩);(2)tau 病(进行性核上性麻痹、皮质基底节变性、额颞叶痴呆 17;关岛帕金森病痴呆;Pick 病等);(3)多聚谷氨酰胺病(亨廷顿病和相关疾病);(4)泛酸激酶相关神经退行性变;(5)威尔逊病;和(6)其他遗传性神经退行性变,目前尚未发现遗传或特定标志物。表型的多样性与病理蛋白在不同细胞群体中的沉积有关,导致遗传和环境因素引起的神经退行性变,但各种疾病之间经常重叠。它们的病因发病机制仍知之甚少,但据推测是由于遗传和环境因素的相互作用。多种病因和有害因素(蛋白质处理不当、线粒体功能障碍、氧化应激、兴奋性毒性、能量衰竭和慢性神经炎症)比单一因素更有可能。目前的临床共识标准提高了大多数神经退行性运动障碍的诊断准确性,但为了明确诊断,需要进行组织病理学确认。我们分两部分及时概述了主要锥体外系运动障碍的神经病理学和发病机制,第一部分专门介绍运动减少性僵硬形式,第二部分专门介绍运动过多障碍。